NCT00987844

Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation

A Study to Evaluate the Long-Term Tolerability, Safety, Patient Satisfaction, Pharmacokinetics, and Use Patterns of Oral Prucalopride Tablets in Patients With Chronic Constipation

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,775 (actual)
• Sponsor: Movetis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Objectives: To evaluate the clinical long-term safety and the tolerability, patient satisfaction, pharmacokinetics and use of pattern of prucalopride given in doses up to 4 mg per day to patients with chronic constipation (CC).

Conditions

• Chronic Constipation

Interventions

Type	Name	Description
DRUG	Prucalopride	1 mg tablets, free dosing regiment with max. of 4 tablets o.d., treatment duration: up to 24 months

Timeline

• Start date: 1998-07-01
• Primary completion: 2000-11-01
• First posted: 2009-10-01
• Last updated: 2009-10-01

Locations

1 site across 1 country: United States